{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:44:30Z","timestamp":1792640670431,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2008,6,5]],"date-time":"2008-06-05T00:00:00Z","timestamp":1212624000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1245\/s10434-008-9988-9","type":"journal-article","created":{"date-parts":[[2008,6,4]],"date-time":"2008-06-04T16:19:43Z","timestamp":1212596383000},"page":"2195-2205","source":"Crossref","is-referenced-by-count":137,"title":["Isolated Limb Infusion for In-Transit Malignant Melanoma of the Extremity: A Well-Tolerated but Less Effective Alternative to Hyperthermic Isolated Limb Perfusion"],"prefix":"10.1245","volume":"15","author":[{"given":"Georgia M.","family":"Beasley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca P.","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"McMahon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Aloia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Petros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gretchen","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsung-Yen","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott K.","family":"Pruitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilliard","family":"Seigler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas S.","family":"Tyler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,6,5]]},"reference":[{"key":"9988_CR1","first-page":"1612","volume-title":"Cancer: Principles and Practice of Oncology","author":"CM Balch","year":"1993","unstructured":"Balch CM, Houghton AN, Peters LJ. (1993) Cutaneous melanoma. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology, 4th edition. JB Lippincott, Philadelphia. p. 1612","edition":"4"},{"key":"9988_CR2","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1245\/ASO.2004.08.016","volume":"11","author":"TW Pawlik","year":"2004","unstructured":"Pawlik TW, Ross MI, Johnson MM, et\u00a0al. Predictors and natural history of in-transit melanoma after sentinel lymphadenectomy. Ann Surg Oncol 2004; 11:1612\u201461","journal-title":"Ann Surg Oncol"},{"key":"9988_CR3","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1002\/1097-0142(19850601)55:11<2638::AID-CNCR2820551118>3.0.CO;2-E","volume":"55","author":"DR Minor","year":"1985","unstructured":"Minor DR, Allen RE, Alberts D, et\u00a0al. A clinical and pharmacokinetic study of isolated limb perfusion with heat and melphalan for melanoma. Cancer 1985; 55:2638\u201344","journal-title":"Cancer"},{"key":"9988_CR4","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1002\/1097-0142(19890615)63:12<2551::AID-CNCR2820631233>3.0.CO;2-7","volume":"63","author":"F Di Filippo","year":"1989","unstructured":"Di Filippo F, Calabro A, Giannarelli D, et\u00a0al. Prognostic variables in recurrent limb melanoma treated with hyperthermic aniblastic perfusion. Cancer 1989; 63:2551\u201361","journal-title":"Cancer"},{"key":"9988_CR5","first-page":"39","volume":"115","author":"JM Klaase","year":"1994","unstructured":"Klaase JM, Kroon BBR, van Geel AN, et\u00a0al. Prognostic factors for tumor response and limb recurrence-free interval in patients with advanced melanoma of the limbs treated with regional isolated perfusion with melphalan. Surgery 1994; 115:39\u201345","journal-title":"Surgery"},{"key":"9988_CR6","first-page":"4411","volume":"7","author":"BR Kroon","year":"1987","unstructured":"Kroon BR, van Geel AN, Benckhuijsen C, et\u00a0al. Normothermic isolation perfusion with melphalan for advanced melanoma of the limbs. Anticancer Res 1987; 7:4411\u20132","journal-title":"Anticancer Res"},{"key":"9988_CR7","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1007\/BF02640542","volume":"9","author":"DL Fraker","year":"2002","unstructured":"Fraker DL, Alexader HR, Ross M, et\u00a0al. A phase III trial of isolated limb infusion perfusion for extremity melanoma comparing melphalan alone versus melphalan plus tumor necrosis factor (TNF-\u03b1) plus interferon-gamma (IFN). Ann Surg Oncol 2002; 9:S8","journal-title":"Ann Surg Oncol"},{"key":"9988_CR8","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/bjs.1800770716","volume":"77","author":"AL Skene","year":"1990","unstructured":"Skene AL, Bulman AS, Williams TF, et\u00a0al. Hyperthermic isolated limb perfusion with melphalan in the treatment of advanced malignant melanoma of the lower limb. Br J Surg 1990; 77:765\u20137","journal-title":"Br J Surg"},{"key":"9988_CR9","volume-title":"Cutaneous Melanoma","author":"DL Fraker","year":"2003","unstructured":"Fraker DL, Eggermont AMM. (2003) Hyperthermic regional perfusion for melanoma of the limbs. In: Balch H, Sober S, eds. Cutaneous Melanoma, 14th edition. Quality Medical, St. Louis, MO","edition":"14"},{"key":"9988_CR10","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/01.sla.0000251746.02764.fc","volume":"245","author":"A Sanki","year":"2007","unstructured":"Sanki A, Kam PCA, Thompson JF. Long-term results of hyperthermic, isolated limb perfusion for melanoma. Ann Surg 2007; 245:591\u20136","journal-title":"Ann Surg"},{"key":"9988_CR11","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/(SICI)1098-2388(199804\/05)14:3<238::AID-SSU8>3.0.CO;2-9","volume":"14","author":"JF Thompson","year":"1998","unstructured":"Thompson JF, Kam PC, Waugh RC, et\u00a0al. Isolated limb infusion with cytotoxic agents: a simple alternative to isolated limb perfusion. Semin Surg Oncol 1998;14:238\u201347","journal-title":"Semin Surg Oncol"},{"key":"9988_CR12","first-page":"188","volume":"7","author":"JF Thompson","year":"1994","unstructured":"Thompson JF, Waugh RC, Saw RPM, et\u00a0al. Isolated limb infusion with melphalan for recurrent limb melanoma: a simple alternative to isolated limb perfusion. Regional Cancer Treat 1994;7:188\u201392","journal-title":"Regional Cancer Treat"},{"key":"9988_CR13","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1245\/aso.2002.9.2.127","volume":"9","author":"P Lindner","year":"2002","unstructured":"Lindner P, Doubrovsky A, Kam PCA, et\u00a0al. Prognostic factors after isolated limb infusion with cytotoxic agents for melanoma. Ann Surg Oncol 2002;9:127\u201336","journal-title":"Ann Surg Oncol"},{"key":"9988_CR14","doi-asserted-by":"crossref","first-page":"4196","DOI":"10.1200\/JCO.2005.05.5152","volume":"24","author":"WR Cornett","year":"2006","unstructured":"Cornett WR, McCall LM, Petersen RP, et\u00a0al. Prospective randomized multicenter trial of hyperthermic isolated limb perfusion with melphalan alone versus melphalan plus tumor necrosis factor: American College of Surgeons Oncology Group Trial Z0020. J Clin Oncol 2006; 24:4196\u2013201","journal-title":"J Clin Oncol"},{"key":"9988_CR15","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1245\/ASO.2006.05.003","volume":"13","author":"MS Brady","year":"2006","unstructured":"Brady MS, Brown K, Patel A, et\u00a0al. A phase II trial of isolated limb infusion with melphalan and dactinomycin for regional melanoma and soft tissue sarcoma of the extremity. Ann Surg Oncol 2006;13:1123\u20139","journal-title":"Ann Surg Oncol"},{"key":"9988_CR16","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1001\/archsurg.140.11.1115","volume":"140","author":"TA Aloia","year":"2005","unstructured":"Aloia TA, Grubbs E, Onaitis M, et\u00a0al. Predictors of outcome after hyperthermic limb perfusion: role of tumor response. Arch Surg 2005; 140:1115\u201320","journal-title":"Arch Surg"},{"key":"9988_CR17","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0378-4347(00)83648-8","volume":"380","author":"H Ehrsson","year":"1986","unstructured":"Ehrsson H, Eksborg S, Lindfors A. Quantitative determination of melphalan in plasma by liquid chromatography after derivatization with N-acetylcysteine. J Chromatogr Biomed Appl 1986; 380:220","journal-title":"J Chromatogr Biomed Appl"},{"key":"9988_CR18","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1200\/JCO.2001.19.16.3635","volume":"19","author":"CM Balch","year":"2001","unstructured":"Balch CM, Buzaid AC, Soong SJ, et\u00a0al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 2001;19:3635\u201348","journal-title":"J Clin Oncol"},{"key":"9988_CR19","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.amjsurg.2003.07.019","volume":"186","author":"T-Y Cheng","year":"2003","unstructured":"Cheng T-Y, Grubbs E, Abdul-Wahab O, et\u00a0al. Marked variability of melphalan plasma drug levels during regional hyperthermic isolated limb perfusion. Am J Surg 2003; 186:460\u20137","journal-title":"Am J Surg"},{"key":"9988_CR20","unstructured":"Zager JS, Gershenwald JE, Aldrink J, et\u00a0al. Isolated limb infusion for locally recurrent and in-transit extremity melanoma: combined institutional initial experience. Presented at Society of Surgical Oncology 59th annual cancer symposium. San Diego, CA March 23\u201326, 2006"},{"key":"9988_CR21","unstructured":"Brady MS, Patel A, Brown K, et\u00a0al. Isolated limb infusion for patients with advanced extremity melanoma and soft tissue sarcoma. Final report of a Phase II trial. Presented at Society of Surgical Oncology 60th annual cancer symposium. Washington, DC March 15\u201318, 2007"},{"key":"9988_CR22","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0360-3016(91)90106-E","volume":"20","author":"DW Siemann","year":"1991","unstructured":"Siemann DW, Chapman M, Beikrich A. Effects of oxygenation and pH on tumor cell response to aklylating chemotherapy. Int J Radiat Oncol Biol Phys 1991; 20:287\u20139","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"9988_CR23","first-page":"305","volume":"129","author":"JS Stehlin","year":"1969","unstructured":"Stehlin JS. Hyperthermic perfusion with chemotherapy for cancers of the extremity. Surg Gynecol Obstet 1969; 129:305","journal-title":"Surg Gynecol Obstet"},{"key":"9988_CR24","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/bjs.1800770716","volume":"77","author":"AL Skene","year":"1990","unstructured":"Skene AL, Bulman AS, Williams TF, et\u00a0al. Hyperthermic isolated limb perfusion with melphalan in the treatment of advanced malignant melanoma of the lower limb. Br J Surg 1990; 77:765\u20137","journal-title":"Br J Surg"},{"key":"9988_CR25","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/0002-9610(85)90006-6","volume":"15","author":"FK Storm","year":"1985","unstructured":"Storm FK, Morton DL. Value of therapeutic hyperthermic limb perfusion in advanced recurrent melanoma of the lower extremity. Am J Surg 1985; 15:32\u20135","journal-title":"Am J Surg"},{"key":"9988_CR26","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1002\/1097-0142(19850601)55:11<2638::AID-CNCR2820551118>3.0.CO;2-E","volume":"55","author":"DR Minor","year":"1985","unstructured":"Minor DR, Allen RE, Alberts D, et\u00a0al. A clinical and pharmacokinetic study of isolated limb perfusion with heat and melphalan for melanoma. Cancer 1985; 55:2638\u201344","journal-title":"Cancer"},{"key":"9988_CR27","first-page":"101","volume":"14","author":"BB Kroon","year":"1998","unstructured":"Kroon BB. Regional isolated perfusion in melanoma of the limbs: accomplishments, unsolved problems, future. Eur J Surg Oncol 1998;14:101\u201310","journal-title":"Eur J Surg Oncol"},{"key":"9988_CR28","doi-asserted-by":"crossref","first-page":"5919","DOI":"10.1158\/1078-0432.CCR-04-0096","volume":"10","author":"OI Abdel-Wahab","year":"2004","unstructured":"Abdel-Wahab OI, Grubbs E, Viglianti B. The role of hyperthermia in regional alkylating agent chemotherapy. Clin Can Res 2004;10:5919\u201329","journal-title":"Clin Can Res"},{"key":"9988_CR29","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1040-8428(01)00179-2","volume":"43","author":"B Hildebrandt","year":"2002","unstructured":"Hildebrandt B, Wust P, Ahlers O. The cellular and molecular basis of hyperthermia. Crit Rev Oncol\/Hematol 2002; 43:33\u201356","journal-title":"Crit Rev Oncol\/Hematol"},{"key":"9988_CR30","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1001\/archsurg.1997.01430320105017","volume":"132","author":"JF Thompson","year":"1997","unstructured":"Thompson JF, Hunt JA, Shannon KF, et\u00a0al. Frequency and duration of remission after isolated limb perfusion for melanoma. Arch Surg 1997; 132:903\u20137","journal-title":"Arch Surg"},{"key":"9988_CR31","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/0277-5379(82)90235-8","volume":"18","author":"J Wieberdink","year":"1982","unstructured":"Wieberdink J, Benckhuijsen C, Braat RP. Dosimetry in isolated perfusion of the limbs by assessment of perfused tissue and grading of toxic tissue reactions. Eur J Cancer Clin Oncol 1982; 18:905\u201310","journal-title":"Eur J Cancer Clin Oncol"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-008-9988-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-008-9988-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-008-9988-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T11:32:06Z","timestamp":1572953526000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-008-9988-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6,5]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["9988"],"URL":"https:\/\/doi.org\/10.1245\/s10434-008-9988-9","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,6,5]]}}}